MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATION. - Wikidata - wikimedia - TriplyDB

MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATION.

MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATION.

http://www.wikidata.org/entity/Q33683865

about

Management of epilepsy during pregnancy: an update Mood stabilizers in pregnancy and lactation Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review Epilepsy (generalised seizures).The risks associated with the use of lamotrigine during pregnancy.Use of Antiepileptic Drugs During Pregnancy: Evolving Concepts.Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters Are doses of lamotrigine or levetiracetam adjusted during pregnancy?

P2860

Q26752470-677BA0EA-9422-4BB0-B85E-2AFB37DD6381 Q26795394-C5AF5AC3-BE29-4174-8647-6C66098C6BD0 Q28109657-DE389B38-7FF0-455A-9F6C-BD3D292E6BCC Q35454020-5942A74D-A5B9-4AC8-B1D2-0D2019337986 Q39402217-60B6EAF5-ACB7-4354-AFF9-A4DCB78A7366 Q39510801-D4CF21BC-8DA7-44A0-A829-63762575B6DB Q42282801-656CD199-39EB-4FD4-82E7-FA8ED9658218 Q53834382-EAB98801-9891-4BFA-9C62-419C6B7328DC

P2860

MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATION.

http://www.wikidata.org/entity/Q33683865

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATION.

@ast

MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATION.

@en

type

label

MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATION.

@ast

MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATION.

@en

prefLabel

MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATION.

@ast

MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATION.

@en

P1433

Q33683865-16A631FD-8D4F-4B85-B7C3-BF70DB5442EF

P1476

Q33683865-4F8EF1C7-59C6-47F9-B3CE-B5C349D16BB3

P2093

Q33683865-4BAF8A6A-EDC8-4DFE-BC3C-17C052916C39

Q33683865-8F2338D5-7543-4DF8-BA1E-4979161DDB37

Q33683865-8F5B00F9-D92E-4C4C-A269-AFB71C567443

Q33683865-D14D1B00-8C7F-4328-8534-B101CCDB0CE4

Q33683865-E136DEEF-1D4F-485D-8895-46B3DCD8F938

Q33683865-E7B1389C-5FA3-4BDB-B057-B563D95010C5

Q33683865-EA68391B-CB41-4D54-B470-FAE0FED5E286

P2860

Q33683865-035DA21F-37CD-4A74-B534-9D1D0D048B86

Q33683865-0498CBB8-E5A6-43AF-9DC6-F80B60040BFB

Q33683865-0B69C122-5EB2-4B2D-B2CB-B23E1CF5333C

Q33683865-1157ACBB-AE15-40A4-A2A8-78129A37286E

Q33683865-1B06D292-5124-488C-A89F-C4EFAF83EE30

Q33683865-22807D45-A2BB-4C70-B53C-00A216DFB5E9

Q33683865-29449C7B-9317-4492-8264-DD2802C11C89

Q33683865-44E411BE-B9C9-4CA1-8B1A-199EC843E89F

Q33683865-49487B35-15CB-4B9A-8DC0-6DA538BB9399

Q33683865-4D8F8906-E326-425C-AA1A-C33A5B7F3323

P304

Q33683865-AE98DEEA-F414-48D0-87DE-51E170DF59C7

P31

Q33683865-3D79431F-DE7F-4E0C-A25D-1DCE7CE3D583

P356

Q33683865-CA8C23F4-CAB7-4215-9F37-32057F9F6DCF

P433

Q33683865-35444B8B-D02B-481B-8CDB-F6910C6D3283

P478

Q33683865-1A8FDF28-B0F4-4B01-B114-F4A701359A43

P50

Q33683865-8CC022EE-26D7-4CDB-B65A-540243210645

P577

Q33683865-E82E3F00-B77A-4CB9-8C46-3125E98C9537

P5875

Q33683865-2A5C6D39-B3FD-4FB6-9563-A647CB349078

P698

Q33683865-65CFC442-FD3E-4EC0-811B-117264014920

P932

Q33683865-63DE6DE7-1881-41F3-AFF6-86D5706BD12F

P356

P1433

Annals of clinical and translational neurology

P1476

MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATION

@en

P2093

Adele C Viguera

http://www.w3.org/2001/XMLSchema#string

Akshanth R Polepally

http://www.w3.org/2001/XMLSchema#string

Angela K Birnbaum

http://www.w3.org/2001/XMLSchema#string

James C Ritchie

http://www.w3.org/2001/XMLSchema#string

Page B Pennell

http://www.w3.org/2001/XMLSchema#string

Richard C Brundage

http://www.w3.org/2001/XMLSchema#string

Zachary N Stowe

http://www.w3.org/2001/XMLSchema#string

P2860

Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.

Population pharmacokinetics of lamotrigine with data from therapeutic drug monitoring in German and Spanish patients with epilepsy.

Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.

Antiepileptic drugs in women with epilepsy during pregnancy

Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations.

Expression of UDP-glucuronosyltransferase 1A4 in human placenta at term.

Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology

Pharmacokinetics and safety of lamotrigine (Lamictal) in patients with epilepsy.

Antiepileptic drug pharmacokinetics during pregnancy and lactation.

Management of bipolar disorder during pregnancy and the postpartum period.

P304

99-106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ACN3.29

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

D Jeffrey Newport

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260306139

http://www.w3.org/2001/XMLSchema#string

P698

24883336

http://www.w3.org/2001/XMLSchema#string

P932

4038031

http://www.w3.org/2001/XMLSchema#string